Index/PramlintideGLP-1 / Metabolic

PRAMLINTIDE

Symlin · Amylin Analog

Amylin analog — glucose control and satiety.

FDA

Approved

WADA

Not Listed

HALF-LIFE

~48 minutes

ROUTE

SubQ injection (before meals)

SCHEDULE

3× daily (before meals)

In Plain English

Amylin analog — glucose control and satiety.

Status & Legality

NATTY?

No Test Exists

No established test exists for this compound.

FDA

Approved

FDA approved for human use.

WADA

Not Listed

Not currently on WADA prohibited list.

COMPOUNDING

Rx Available

Available at licensed pharmacies with prescription.

PRESCRIBED

By prescription

Physicians can prescribe this compound legally.

ROUTE

SubQ injection (before meals)

Administration via subq injection (before meals).

Who It's For

Blood sugar control

Satiety enhancement

Weight management

Diabetes adjunct

How It Works

Pramlintide is a synthetic analog of amylin, a peptide co-secreted with insulin from pancreatic beta cells. It slows gastric emptying, reduces post-meal glucagon secretion, and induces satiety — resulting in lower post-meal blood sugar spikes and reduced caloric intake. FDA-approved as an adjunct to insulin.

Side Effects

01

Nausea (most common)

02

Hypoglycemia (if insulin not reduced)

03

Vomiting

04

Anorexia

Common Mistakes

Mixing pramlintide and insulin in the same syringe — they are physically incompatible and will clump

Not reducing mealtime insulin by 50% when starting — severe hypoglycemia is the most dangerous side effect

Using it for weight loss without insulin-dependent diabetes — semaglutide is more effective and simpler for pure appetite suppression

Drug & Supplement Interactions

Insulin — critical to reduce mealtime insulin dose by 50% when initiating; hypoglycemia risk is significant

Sulfonylureas — additive hypoglycemia risk; monitor blood glucose closely

Oral medications — slowed gastric emptying delays absorption and peak blood levels of all oral drugs

The PepVault Take

Pramlintide is most valuable for insulin-dependent diabetics struggling with post-meal spikes despite adequate insulin dosing. It works differently from GLP-1s — through amylin receptors, not GLP-1 receptors — meaning it adds a distinct mechanism. For non-diabetics seeking appetite control, semaglutide is significantly more effective and simpler to use.

Frequently Asked Questions

Stats

ONSET50
DOCUMENTATION92
SIDE INTENSITY49
CYCLE EASE70
POPULARITY25
Add to My Stack
Real human support, no ticket queue.
Stuck on a protocol, billing, or anything else? support@pepvault.co — replies usually inside 24 hours.
Email Support
Research Use OnlyNot Medical AdviceNot FDA Evaluated18+ OnlyWADA Status Tracked

PepVault provides educational and research reference information only. Nothing on this site constitutes medical advice, diagnosis, or treatment. Content has not been evaluated by the U.S. Food and Drug Administration. No compound listed on this site is intended to diagnose, treat, cure, or prevent any disease or medical condition. The legality of peptide compounds varies by jurisdiction — you are solely responsible for compliance with the laws of your country or region. Certain compounds listed are prohibited under the World Anti-Doping Agency (WADA) Prohibited List; athletes subject to anti-doping regulations should independently verify status before use. This site is intended for adults 18 years of age or older. Always consult a licensed healthcare provider before using any compound.

© 2026 PepVault. All rights reserved.